Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Autoimmune Disorders

Free Subscription 19.05.2025 1 Brain 4 Diabet Med 3 Intern Med 1 J Clin Endocrinol Metab 7 J Neurol 1 J Pediatr 2 J Pediatr Endocrinol Metab 4 J Rheumatol 4 N Engl J Med 1 Nat Rev Neurol 1 Neurology 2 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Brain

1. FENG YF, Zeng ZK, Ni Y, Hu Y, et al
   Parvalbumin neurons mediate neurological phenotypes of anti-NMDAR encephalitis.
   Brain. 2025;148:1652-1664.
   PubMed         Abstract available
   
   

   
   Diabet Med

2. SIGLEY R, Boggiss AL, Albert B, Han DY, et al
   Psychological and self care outcomes for children and adolescents living with type 1 diabetes and their caregivers attending diabetes camp: A mixed methods study.
   Diabet Med. 2025 Apr 2:e70038. doi: 10.1111/dme.70038.
   PubMed         Abstract available
   
   
3. YU J, Wang H, Zhou M, Zhu M, et al
   Impact of ultrasound-diagnosed lipohypertrophy subtypes on insulin regimen adjustments in patients with T1DM.
   Diabet Med. 2025;42:e70034.
   PubMed         Abstract available
   
   
4. HAAS J, Persson M, Toft EH, Back-Nirs J, et al
   Improved self-management of type 1 diabetes in young women: Experiences of Guided Self-Determination-Young: A qualitative interview study.
   Diabet Med. 2025 Mar 28:e70029. doi: 10.1111/dme.70029.
   PubMed         Abstract available
   
   
5. ZAFRA-TANAKA JH, Del Valle A, Pastrana NA, Miranda JJ, et al
   Patient relevant outcomes for type 1 diabetes management: A qualitative evidence synthesis.
   Diabet Med. 2025 Mar 20:e70016. doi: 10.1111/dme.70016.
   PubMed         Abstract available
   
   

   
   Intern Med

6. HIRAI M, Mori M, Sakai T, Oka T, et al
   Management of Concurrent Immune Thrombocytopenia and Ulcerative Colitis: A Case Report and Literature Review.
   Intern Med. 2025;64:1569-1573.
   PubMed         Abstract available
   
   
7. SAIKI R, Katayama K, Akiyama E, Oda K, et al
   Latent Tubulointerstitial Nephritis with IgM-positive Plasma Cells Uncovered in a Case of IgA Nephropathy and Primary Biliary Cholangitis: Clinical and Histological Insights.
   Intern Med. 2025 May 15. doi: 10.2169/internalmedicine.5217.
   PubMed         Abstract available
   
   
8. KIMURA R, Hayashi T, Fukazawa M, Kimura K, et al
   A Case of Gastrointestinal Perforation in Guillain-Barre Syndrome.
   Intern Med. 2025 May 15. doi: 10.2169/internalmedicine.5190.
   PubMed        
   
   

   
   J Clin Endocrinol Metab

9. ZHANG Y, Alzahrani M, Luu T, Fatunbi J, et al
   Dyslipidemia is associated with increased NK cell cytotoxicity and autoimmunity in women with recurrent pregnancy losses.
   J Clin Endocrinol Metab. 2025 May 15:dgaf283. doi: 10.1210.
   PubMed         Abstract available
   
   

   
   J Neurol

10. FILIPPI M, Preziosa P, Rocca MA
    Randomized controlled trials for multiple sclerosis: integrating pathology-driven outcomes to capture therapeutic efficacy.
    J Neurol. 2025;272:385.
    PubMed        
    
    
11. KIM YS, Shin IJ, Park DG, Yoon JH, et al
    Hashimoto's encephalopathy with diffuse leukoencephalopathy: serial MRI and gait analysis.
    J Neurol. 2025;272:399.
    PubMed        
    
    
12. HU S, Liao Z, Wang R, Zhang M, et al
    Relapse risk after rituximab discontinuation in neuromyelitis optica spectrum disorders: a multi-center retrospective cohort study.
    J Neurol. 2025;272:387.
    PubMed         Abstract available
    
    
13. ROCCA MA, Ratzinger S, Preziosa P, Meani A, et al
    Clinical integration of brain and cord MRI features improves differential diagnosis of multiple sclerosis.
    J Neurol. 2025;272:388.
    PubMed         Abstract available
    
    
14. TARANU D, Balz LT, Holbrook J, Tumani V, et al
    Cognitive impairment, mood, and fatigue in various multiple sclerosis subtypes: a one-year follow-up study.
    J Neurol. 2025;272:398.
    PubMed         Abstract available
    
    
15. ROSSINI E, Di Stefano V, Iorio R, Habetswallner F, et al
    Ravulizumab for generalized Myasthenia Gravis: a multicenter real-life experience.
    J Neurol. 2025;272:396.
    PubMed         Abstract available
    
    
16. FREEDMAN MS, Abdelhak A, Bhutani MK, Freeman J, et al
    The role of serum neurofilament light (sNfL) as a biomarker in multiple sclerosis: insights from a systematic review.
    J Neurol. 2025;272:400.
    PubMed         Abstract available
    
    

    
    J Pediatr

17. JORGENSEN MH, Almaas R, Kharrazi G, Urbonas V, et al
    Various Regimens for Autoimmune Hepatitis in Northern European Children Show Equivalent Outcomes at 1 Year: A Retrospective Study.
    J Pediatr. 2025 May 7:114635. doi: 10.1016/j.jpeds.2025.114635.
    PubMed         Abstract available
    
    

    
    J Pediatr Endocrinol Metab

18. CAN YILMAZ G, Karadag M
    Chronotype, sleep, and glycemic control in children and adolescents with type 1 diabetes: a case-control study.
    J Pediatr Endocrinol Metab. 2025;38:442-449.
    PubMed         Abstract available
    
    
19. PLATNICK C, Choi YJ, Narongkiatikhun P, Bekelman N, et al
    Relationships among biological sex, body composition, and bone mineral density in young persons with and without diabetes.
    J Pediatr Endocrinol Metab. 2025;38:476-487.
    PubMed         Abstract available
    
    

    
    J Rheumatol

20. RODRIGUEZ-REYNA TS
    The Nuances of Shared Autoimmunity and the Singularity of Mixed Connective Tissue Disease.
    J Rheumatol. 2025 May 15:jrheum.2025-0463. doi: 10.3899/jrheum.2025-0463.
    PubMed        
    
    
21. JIANG Z, Barra L
    Does Prior Authorization for Tocilizumab Lead to Unacceptable Treatment Delays in Giant Cell Arteritis?
    J Rheumatol. 2025 May 15:jrheum.2025-0423. doi: 10.3899/jrheum.2025-0423.
    PubMed        
    
    
22. PIRES DA ROSA G, Granja BV, Azevedo F, Magina S, et al
    Pyoderma Gangrenosum-Associated Autoinflammatory Syndrome With Skin Abscesses: Successful Treatment With Anti-Interleukin 1 Therapy.
    J Rheumatol. 2025 May 15:jrheum.2025-0036. doi: 10.3899/jrheum.2025-0036.
    PubMed        
    
    
23. GUNGORER V, Celik IK, Artac H, Celikel Acar B, et al
    OTULIN-Related Autoinflammatory Syndrome With a Novel Mutation Treated With Tumor Necrosis Factor Inhibitor Therapy: A Rare Case Report.
    J Rheumatol. 2025 May 15:jrheum.2024-1141. doi: 10.3899/jrheum.2024-1141.
    PubMed        
    
    

    
    N Engl J Med

24. ANGELETTI A, Marasa M, Cravedi P
    Alternative Complement Pathway, Iptacopan, and IgA Nephropathy.
    N Engl J Med. 2025;392:1976.
    PubMed        
    
    
25. POPPELAARS F, Faria B, Thurman JM
    Alternative Complement Pathway, Iptacopan, and IgA Nephropathy.
    N Engl J Med. 2025;392:1975.
    PubMed        
    
    
26. BARRATT J, Perkovic V, Rizk DV
    Alternative Complement Pathway, Iptacopan, and IgA Nephropathy. Reply.
    N Engl J Med. 2025;392:1976.
    PubMed        
    
    
27. CALABRESI PA
    Progress toward Mitigating Disability Progression in Multiple Sclerosis.
    N Engl J Med. 2025;392:1966-1968.
    PubMed        
    
    

    
    Nat Rev Neurol

28. KIANI L
    Genetic susceptibility determines Epstein-Barr-virus-associated risk of multiple sclerosis.
    Nat Rev Neurol. 2025 May 12. doi: 10.1038/s41582-025-01099.
    PubMed        
    
    

    
    Neurology

29. KRIJNEN EA, Jelgerhuis J, Van Dam M, Bouman PM, et al
    Evolution of Cortical Lesions and Function-Specific Cognitive Decline in People With Multiple Sclerosis.
    Neurology. 2025;104:e213650.
    PubMed         Abstract available
    
    

    
    PLoS One

30. HERMINE O, Gros L, Tran TA, Loussaief L, et al
    Tyrosine kinase inhibitor, masitinib, limits neuronal damage, as measured by serum neurofilament light chain concentration in a model of neuroimmune-driven neurodegenerative disease.
    PLoS One. 2025;20:e0322199.
    PubMed         Abstract available
    
    
31. MITTAL R, McKenna K, Lemos JRN, Juneja S, et al
    Therapeutic potential of anti-thymocyte globulin in type 1 diabetes: A systematic review.
    PLoS One. 2025;20:e0323642.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge.